Nabumetone
Product Images NDC 42549-648

12 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 42549-648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)
Chemical structure of nabumetone, showing a fused bicyclic ring with a methoxy group and a side chain containing a ketone group. Molecular formula C15H16O2 and molecular weight 228.3 are displayed beneath the structure.*
FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)
Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of nabumetone. The structure includes a methoxy group on a naphthalene ring and a side chain with a carboxylic acid group.*
FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)
A data table presenting pharmacokinetic parameters for young adults and elderly subjects at different doses. It lists Tmax (hr), t1/2 (hr), clearance (CLss/F mL/min), and volume of distribution (Vdss/F L) with mean and standard deviation values for 1,000 mg and 2,000 mg doses in young adults and 1,000 mg in elderly subjects.*
FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)
A line graph showing Nabumetone active metabolite (6MNA) plasma concentrations over 70 hours at steady state after once-daily dosing of 1000 mg and 2000 mg. The chart includes mean concentrations with plus and minus 2 standard deviation lines for both doses, and shaded areas indicating concentration ranges over time.*
FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)
A data table showing the percentages of various metabolites related to nabumetone, including unchanged nabumetone, 6-methoxy-2-naphthylacetic acid, 6MNA (conjugated), 6-hydroxy-2-naphthylacetic acid (both unchanged and conjugated), 4-(6-hydroxy-2-naphthyl)-butan-2-ol (conjugated), O-desmethyl-nabumetone (conjugated), unidentified minor metabolites, and the total percent dose.*
FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)
A data table showing the number of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) receiving various doses of Nabumetone (500 mg, 1,000 mg, 1,500 mg, and 2,000 mg), along with the mean and mode duration of treatment in years for each group.*
FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)
A drug facts panel listing serious and other side effects of a medication. Serious side effects include heart attack, stroke, high blood pressure, heart failure from fluid retention, kidney problems, bleeding and ulcers, anemia, skin and allergic reactions, liver failure, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*
FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)
A warning text panel listing symptoms including shortness of breath or trouble breathing, chest pain, weakness in one body part, slurred speech, and swelling of the face or throat, likely part of a medication safety section for Nabumetone.*
FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)
A drug information text panel listing possible side effects and symptoms to watch for, including nausea, weakness, itching, yellowing of skin or eyes, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movements or black sticky tar, unusual weight gain, skin rash or blisters with fever, and swelling of arms, legs, hands, and feet.*
FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)
A table listing generic drug names alongside their corresponding tradenames. It includes multiple NSAIDs such as Celecoxib (Celebrex), Diclofenac (Cataflam, Voltaren, Arthrotec), Ibuprofen (Motrin, Tab-Profen, Vicoprofen), Nabumetone (Relafen), and others, showing brand variations and combination products where applicable.*
FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Nabumetone 750mg Label Image (Nabumetone 750 mg Label 42549)

Nabumetone 750mg Label Image (Nabumetone 750 mg  Label  42549)
Nabumetone 750 mg tablet bottle label distributed by STAT Rx USA LLC, Gainesville, GA. The label shows this package contains 30 tablets and is generic for Relafen. It includes the NDC 42549-648-30 and manufacturer information for Glenmark Generics Inc. USA, Mahwah, NJ. The label also features dosage instructions, lot number, and a blue warning stating RX ONLY-KEEP OUT OF REACH OF CHILDREN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.